Rigel Pharmaceuticals Inc (RIGL) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Rigel Pharmaceuticals Inc  (NASDAQ: RIGL)
 

Rigel Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Rigel Pharmaceuticals Inc inventory turnover ratio, the Rigel Pharmaceuticals Inc's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.24 in the third quarter 2026, RIGL's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Rigel Pharmaceuticals Inc in Sep 30 2026 quarter, has decreased to 163 days, compare to 194 days, in the Jun 30 2026 quarter.

Within Healthcare sector 220 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1391 in the second quarter 2026, to 1660.

RIGL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rigel Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RIGL Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 18.81 % 37.84 % 150.1 % 91.7 % 178.07 %
Y / Y Cost of Sales Growth 126.87 % 89.28 % 4.47 % 2.87 % -40.78 %
Inventory Turnover Ratio (TTM) 2.24 1.88 1.69 1.97 2.26
RIGL's Total Ranking # 1660 # 1391 # 1117 # 918 #
Average inventory processing period 163 195 216 186 161
Seq. Inventory Growth 10.01 % 23.3 % 1.27 % -13.51 % 27.63 %
Seq. Cost of Sales Growth 26.49 % 85.08 % -22.65 % 25.29 % 5.53 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 221
Overall Market # 1660

Inventory Turnover Ratio Statistics
High Average Low
3.58 1.06 0.13
(Mar 31 2025)   (Mar 31 2022)



RIGL Company Profile >> Back to RIGL Efficiency Comparisons >> Compare RIGL Inventory Turnover Ratio to its Competitors

Financial Statements
Rigel Pharmaceuticals Inc's Inventories $ 16 Millions Visit RIGL's Balance sheet
Rigel Pharmaceuticals Inc's Cost of Revenues TTM $ 30 Millions Visit RIGL's Income Statement
What are RIGL's Sales? Visit RIGL's Sales by Segment

Other Inventory Turnover Ratios
Rigel Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RIGL's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RIGL's Competitors
Inventory Turnover Ratio for RIGL's Suppliers
Inventory Turnover Ratio for RIGL's Customers

You may also want to know
RIGL's Sales Growth Rates RIGL's Pe Price to earnings ratio RIGL's Receivables Turnover Ratio RIGL's Stock Quote
RIGL's Net Income Growth Rates RIGL's Ps Price to Sales ratio RIGL's Sales per Employee RIGL's Asset Turnover Ratio
RIGL's Net Margin RIGL's Pb Price to Book ratio RIGL's Financial Strength Ratios RIGL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Mirum Pharmaceuticals Inc   2.35 $ 59.684  Millions$ 25  Millions
Aquestive Therapeutics Inc   2.34 $ 16.928  Millions$ 7  Millions
Resmed Inc   2.33 $ 2,214.675  Millions$ 952  Millions
Beta Bionics Inc   2.31 $ 53.285  Millions$ 23  Millions
Merit Medical Systems Inc  2.25 $ 817.001  Millions$ 363  Millions

Date modified: 2026-11-08T10:01:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.